140 related articles for article (PubMed ID: 2667837)
1. The natural history of medication compliance in a drug trial: limitations of pill counts.
Rudd P; Byyny RL; Zachary V; LoVerde ME; Titus C; Mitchell WD; Marshall G
Clin Pharmacol Ther; 1989 Aug; 46(2):169-76. PubMed ID: 2667837
[TBL] [Abstract][Full Text] [Related]
2. Pill count measures of compliance in a drug trial: variability and suitability.
Rudd P; Byyny RL; Zachary V; LoVerde ME; Mitchell WD; Titus C; Marshall G
Am J Hypertens; 1988 Jul; 1(3 Pt 1):309-12. PubMed ID: 3291897
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive efficacy of pinacidil--automatic ambulatory blood pressure monitoring.
Zachariah PK; Sheps SG; Schirger A; Fisher LD; Shub C; Collins JB; Spiekerman RE
Eur J Clin Pharmacol; 1986; 31(2):133-41. PubMed ID: 3803413
[TBL] [Abstract][Full Text] [Related]
4. Long term haemodynamic effects of pinacidil and hydralazine in arterial hypertension.
Carlsen JE; Jensen HA; Rehling M; Lund JO; Trap-Jensen J
Drugs; 1988; 36 Suppl 7():55-63. PubMed ID: 3076136
[TBL] [Abstract][Full Text] [Related]
5. Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring.
Leenen FH; Wilson TW; Bolli P; Larochelle P; Myers M; Handa SP; Boileau G; Tanner J
Can J Cardiol; 1997 Oct; 13(10):914-20. PubMed ID: 9374947
[TBL] [Abstract][Full Text] [Related]
6. Double-blind comparator trials with pinacidil, a potassium channel opener.
Callaghan JT; Goldberg MR; Brunelle R
Drugs; 1988; 36 Suppl 7():77-82. PubMed ID: 3076139
[TBL] [Abstract][Full Text] [Related]
7. Comparison of antihypertensive, renal hemodynamic, and humoral effects of pinacidil and hydralazine monotherapy.
Abraham PA; Halstenson CE; Matzke GR; Keane WF
J Clin Hypertens; 1987 Dec; 3(4):439-51. PubMed ID: 3330986
[TBL] [Abstract][Full Text] [Related]
8. Acute hemodynamic effects of pinacidil and hydralazine in essential hypertension.
Carlsen JE; Kardel T; Lund JO; McNair A; Trap-Jensen J
Clin Pharmacol Ther; 1985 Mar; 37(3):253-9. PubMed ID: 2857601
[TBL] [Abstract][Full Text] [Related]
9. A double-blind, randomized, controlled trial comparing pinacidil to hydralazine in essential hypertension.
Byyny RL; Nies AS; LoVerde ME; Mitchell WD
Clin Pharmacol Ther; 1987 Jul; 42(1):50-7. PubMed ID: 3297468
[TBL] [Abstract][Full Text] [Related]
10. Improved compliance measures: applications in an ambulatory hypertensive drug trial.
Rudd P; Ahmed S; Zachary V; Barton C; Bonduelle D
Clin Pharmacol Ther; 1990 Dec; 48(6):676-85. PubMed ID: 2147405
[TBL] [Abstract][Full Text] [Related]
11. Preliminary evaluation of pinacidil in hypertension.
Ramsay LE; Freestone S
Br J Clin Pharmacol; 1983 Sep; 16(3):336-8. PubMed ID: 6626426
[TBL] [Abstract][Full Text] [Related]
12. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
[TBL] [Abstract][Full Text] [Related]
13. Impact of an electronic medication compliance aid on long-term blood pressure control.
McKenney JM; Munroe WP; Wright JT
J Clin Pharmacol; 1992 Mar; 32(3):277-83. PubMed ID: 1564133
[TBL] [Abstract][Full Text] [Related]
14. Pinacidil with and without hydrochlorothiazide. Dose-response relationships from results of a 4 x 3 factorial design study.
Goldberg MR; Offen WW
Drugs; 1988; 36 Suppl 7():83-92. PubMed ID: 3076140
[TBL] [Abstract][Full Text] [Related]
15. Approach to drug therapy for hypertension.
Kuchel OG; Mahon WA; McKenzie JK; Ogilvie RI
Can Med Assoc J; 1979 Mar; 120(5):565-70. PubMed ID: 35278
[TBL] [Abstract][Full Text] [Related]
16. Pinacidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension.
Friedel HA; Brogden RN
Drugs; 1990 Jun; 39(6):929-67. PubMed ID: 2196168
[TBL] [Abstract][Full Text] [Related]
17. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
18. Effects of long term treatment with pinacidil and nifedipine on left ventricular anatomy and function in patients with mild to moderate systemic hypertension.
Steensgaard-Hansen F; Carlsen JE
Drugs; 1988; 36 Suppl 7():70-6. PubMed ID: 3254831
[TBL] [Abstract][Full Text] [Related]
19. Improvement of medication compliance in uncontrolled hypertension.
Haynes RB; Sackett DL; Gibson ES; Taylor DW; Hackett BC; Roberts RS; Johnson AL
Lancet; 1976 Jun; 1(7972):1265-8. PubMed ID: 73694
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of a hypertension screening program.
Silverberg DS
Can Med Assoc J; 1976 Mar; 114(5):425-8. PubMed ID: 1253087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
